Radiolabeled BC8 Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radiolabeled BC8 Antibody, covering 2017-08-30 to 2017-08-30. Get the full timeline:
Most recent: Clinical Trial Update: Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [Phase 2]